Skip to content

MSH2 PM219H

by Biocare Medical, LLC

Ref PM219H

MSH2 PM219H, a MSH2 antigen IVD (EU IVDD general IVD; FDA Class I; FDA product code NJT, Immunohistochemistry Reagents And Kits) made by Biocare Medical, LLC, was registered in EUDAMED on 5 Nov 2026 (Basic UDI-DI B-00847627014108) and listed in FDA GUDID on 23 Sep 2022 (UDI-DI 00847627014108); the registry lists it as withdrawn as of 7 Nov 2026.

Withdrawn Withdrawn in European Union.

Was authorized under CE IVDD, withdrawn

Ended

Withdrawn

Date not published (CE IVDD)

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00847627014108 Basic UDI-DI 00847627014108UDI-DIDate5 Nov 2026RegisteredStatusWithdrawn
United StatesGUDID listing GUDID Number00847627014108 UDI-DI Date23 Sep 2022ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-00847627014108 registered 5 Nov 2026 Withdrawn
  • FDA GUDID UDI-DI 00847627014108 listed 23 Sep 2022 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00847627014108
  2. Registered EUDAMED B-00847627014108

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Withdrawn
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
MSH2
Generic name
MSH2 antigen IVD, antibody
Model / reference
PM219H
Primary DI / UDI-DI
00847627014108
Basic UDI-DI
B-00847627014108
FDA product code
NJT
EMDN code
W01060214 Colorectal cancer (msi-h / dmmr)
GMDN term
MSH2 antigen IVD, antibody
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
864.1860
EU registration type
Legacy device (under a directive)
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class I

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under COLORECTAL CANCER (MSI-H / DMMR).

Other devices from Biocare Medical, LLC

See all devices from Biocare Medical, LLC →

Properties

  • Contains animal tissues or cells
  • Reagent
  • Professional testing
  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (18, all answered No)